Home | Welcome to Contract Pharma   
Last Updated Thursday, October 23 2014
Print RSS Feed

Breaking News

Related Searches:
September 8, 2010
Bristol-Myers Squibb Co. has agreed to acquire ZymoGenetics, Inc. for $735 million, adding biologics for hepatitis and other diseases to its pipeline.   Read More »
September 8, 2010
Russ Hager has been appointed global director of supply chain at BioStorage Technologies, Inc.   Read More »
September 8, 2010
PPD, Inc. has established preferred provider relationships with a network of sites across North America for conducting Phase I trials.   Read More »
September 8, 2010
AMRI has appointed the four new members to its sales leadership team.  Read More »
September 7, 2010
Roche has launched a group-wide Operational Excellence initiative aimed at “adapting to cost structures and accelerating productivity improvements.” The initiative is scheduled for implementation during 2011 and 2012.  Read More »
September 7, 2010
Bend Research, Inc. is expanding its pharmaceutical manufacturing capabilities for hot-melt extrusion.   Read More »
September 7, 2010
DSM Pharma Chemicals, a business unit of DSM Pharmaceutical Products, has launched InnoSyn route scouting services, a focused and flexible stand-alone system designed to significantly cut costs by the reduction of synthesis steps or redesign of synth…  Read More »
September 7, 2010
Quintiles’ new lab in Tokyo, Japan has received accreditation from the College of American Pathologists (CAP), a network of fully harmonized, CAP-accredited central labs around the world.  Read More »
September 3, 2010
PrePak Holdings, Inc. has acquired TestPak, a health care supply chain company based in Whippany, NJ.  Read More »
September 3, 2010
CLC bio is expanding in both North and South America with the opening of a new location in Boston, MA and a new Government Sector Branch in the Washington, D.C. area.  Read More »
September 3, 2010
Rosemarie Truman has been named executive vice president of solutions at Advanced Clinical.  Read More »
September 2, 2010
Takeda Pharmaceutical Co. Ltd. has entered into an exclusive partnership to develop and commercialize Contrave (naltrexone SR/bupropion SR), Orexigen's investigational drug for the treatment of obesity, in the U.S., Canada and Mexico.   Read More »
September 2, 2010
Veritas Corp. has entered into an agreement with to market and distribute Epistem’s scientific research services in Japan.   Read More »
September 2, 2010
NextPharma has expanded its microbiology facilities at its site in Göttingen, Germany.   Read More »
September 2, 2010
Julie Heneghan has been appointed vice president of Advanced Clinical. Ms. Heneghan has more than 20 years of experience in the outsourcing and staffing solutions industry.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On